167 related articles for article (PubMed ID: 10025668)
1. Osteoclast markers accumulate on cells developing from human peripheral blood mononuclear precursors.
Faust J; Lacey DL; Hunt P; Burgess TL; Scully S; Van G; Eli A; Qian Y; Shalhoub V
J Cell Biochem; 1999 Jan; 72(1):67-80. PubMed ID: 10025668
[TBL] [Abstract][Full Text] [Related]
2. MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption.
Kim MS; Day CJ; Selinger CI; Magno CL; Stephens SR; Morrison NA
J Biol Chem; 2006 Jan; 281(2):1274-85. PubMed ID: 16280328
[TBL] [Abstract][Full Text] [Related]
3. Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors.
Shalhoub V; Faust J; Boyle WJ; Dunstan CR; Kelley M; Kaufman S; Scully S; Van G; Lacey DL
J Cell Biochem; 1999 Feb; 72(2):251-61. PubMed ID: 10022507
[TBL] [Abstract][Full Text] [Related]
4. Human osteoclast and giant cell differentiation: the apparent switch from nonspecific esterase to tartrate resistant acid phosphatase activity coincides with the in situ expression of osteopontin mRNA.
Connor JR; Dodds RA; James IE; Gowen M
J Histochem Cytochem; 1995 Dec; 43(12):1193-201. PubMed ID: 8537635
[TBL] [Abstract][Full Text] [Related]
5. Cellular mechanisms of osteoclast formation and lacunar resorption in giant cell granuloma of the jaw.
Itonaga I; Hussein I; Kudo O; Sabokbar A; Watt-Smith S; Ferguson D; Athanasou NA
J Oral Pathol Med; 2003 Apr; 32(4):224-31. PubMed ID: 12653862
[TBL] [Abstract][Full Text] [Related]
6. Relevance of an in vitro osteoclastogenesis system to study receptor activator of NF-kB ligand and osteoprotegerin biological activities.
Wittrant Y; Theoleyre S; Couillaud S; Dunstan C; Heymann D; Rédini F
Exp Cell Res; 2004 Feb; 293(2):292-301. PubMed ID: 14729467
[TBL] [Abstract][Full Text] [Related]
7. Isolation of human osteoclasts formed in vitro: hormonal effects on the bone-resorbing activity of human osteoclasts.
Kudo O; Sabokbar A; Pocock A; Itonaga I; Athanasou NA
Calcif Tissue Int; 2002 Dec; 71(6):539-46. PubMed ID: 12232680
[TBL] [Abstract][Full Text] [Related]
8. Limited rescue of osteoclast-poor osteopetrosis after successful engraftment by cord blood from an unrelated donor.
Nicholls BM; Bredius RG; Hamdy NA; Gerritsen EJ; Lankester AC; Hogendoorn PC; Nesbitt SA; Horton MA; Flanagan AM
J Bone Miner Res; 2005 Dec; 20(12):2264-70. PubMed ID: 16294279
[TBL] [Abstract][Full Text] [Related]
9. Osteoclast differentiation from circulating mononuclear precursors in Paget's disease is hypersensitive to 1,25-dihydroxyvitamin D(3) and RANKL.
Neale SD; Smith R; Wass JA; Athanasou NA
Bone; 2000 Sep; 27(3):409-16. PubMed ID: 10962353
[TBL] [Abstract][Full Text] [Related]
10. Normal human peripheral blood mononuclear cells mobilized with granulocyte colony-stimulating factor have increased osteoclastogenic potential compared to nonmobilized blood.
Purton LE; Lee MY; Torok-Storb B
Blood; 1996 Mar; 87(5):1802-8. PubMed ID: 8634426
[TBL] [Abstract][Full Text] [Related]
11. Cloning and characterization of osteoclast precursors from the RAW264.7 cell line.
Cuetara BL; Crotti TN; O'Donoghue AJ; McHugh KP
In Vitro Cell Dev Biol Anim; 2006; 42(7):182-8. PubMed ID: 16948499
[TBL] [Abstract][Full Text] [Related]
12. Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis.
Crotti T; Smith MD; Hirsch R; Soukoulis S; Weedon H; Capone M; Ahern MJ; Haynes D
J Periodontal Res; 2003 Aug; 38(4):380-7. PubMed ID: 12828654
[TBL] [Abstract][Full Text] [Related]
13. Pseudosynovial fluid from loosened total hip prosthesis induces osteoclast formation.
Mandelin J; Liljeström M; Li TF; Ainola M; Hukkanen M; Salo J; Santavirta S; Konttinen YT
J Biomed Mater Res B Appl Biomater; 2005 Jul; 74(1):582-8. PubMed ID: 15768436
[TBL] [Abstract][Full Text] [Related]
14. In vitro differentiation of CD14 cells from osteopetrotic subjects: contrasting phenotypes with TCIRG1, CLCN7, and attachment defects.
Blair HC; Borysenko CW; Villa A; Schlesinger PH; Kalla SE; Yaroslavskiy BB; Garćia-Palacios V; Oakley JI; Orchard PJ
J Bone Miner Res; 2004 Aug; 19(8):1329-38. PubMed ID: 15231021
[TBL] [Abstract][Full Text] [Related]
15. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
Michael H; Härkönen PL; Väänänen HK; Hentunen TA
J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
[TBL] [Abstract][Full Text] [Related]
16. Expression of the calcitonin receptor in bone marrow cell cultures and in bone: a specific marker of the differentiated osteoclast that is regulated by calcitonin.
Lee SK; Goldring SR; Lorenzo JA
Endocrinology; 1995 Oct; 136(10):4572-81. PubMed ID: 7664679
[TBL] [Abstract][Full Text] [Related]
17. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor-alpha cooperates with receptor activator of nuclear factor kappaB ligand in generation of osteoclasts in stromal cell-depleted rat bone marrow cell culture.
Komine M; Kukita A; Kukita T; Ogata Y; Hotokebuchi T; Kohashi O
Bone; 2001 May; 28(5):474-83. PubMed ID: 11344046
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of osteoclast-specific gene markers stimulated by lipopolysaccharide.
Jiang J; Li H; Fahid FS; Filbert E; Safavi KE; Spangberg LS; Zhu Q
J Endod; 2006 Aug; 32(8):742-6. PubMed ID: 16861073
[TBL] [Abstract][Full Text] [Related]
20. Cathepsin K mRNA detection is restricted to osteoclasts during fetal mouse development.
Dodds RA; Connor JR; Drake F; Feild J; Gowen M
J Bone Miner Res; 1998 Apr; 13(4):673-82. PubMed ID: 9556067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
